Hiroaki Saito
- Cancer Research top 5%
- NF-κB Signaling Pathways 7
- Oncology top 5%
- Bone health and treatments 21
- Molecular Biology top 5%
- Bone Metabolism and Diseases 24
- Wnt/β-catenin signaling in development and cancer 5
- Cancer-related gene regulation 4
- TGF-β signaling in diseases 4
- Fibroblast Growth Factor Research 3
- Nephrology top 5%
- Parathyroid Disorders and Treatments 5
- Co-authors
- Kazuhiro AokiKeiichi OhyaRoland BaronEric HesseSankar GhoshEijiro JimiFulvio D’AcquistoIchiro Nakamura
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hiroaki Saito
52 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 414
- Orthopedics and Sports Medicine 217
- Oncology 659
- Molecular Biology 1.4k
- Nephrology 132
Countries citing papers authored by Hiroaki Saito
This map shows the geographic impact of Hiroaki Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Saito more than expected).
Fields of papers citing papers by Hiroaki Saito
This network shows the impact of papers produced by Hiroaki Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Saito. The network helps show where Hiroaki Saito may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroaki Saito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 8 | |
| 8 | 2019 | 33 | |
| 9 | 2019 | 89 | |
| 10 | 2019 | 55 | |
| 11 | 2016 | 94 | |
| 12 | 2013 | 39 | |
| 13 | 2012 | 44 | |
| 14 | 2012 | 14 | |
| 15 | Clinical Findings on Fibroblast Activation Protein in Patients with Gastric Cancer | 2009 | 3 |
| 16 | 2009 | 43 | |
| 17 | 2007 | 52 | |
| 18 | Three-Dimensional Measurements of Bone Resorption Lacunae Reveal Inhibition of Osteoclast Activity by TNF-α Antagonist In Vitro | 2006 | 3 |
| 19 | 2006 | 113 | |
| 20 | 18. Effect of PMSG on Chromosome Aberration and Sister Chromatid Exchange on in vitro and in vivo Fertilized Mouse Oocytes | 1985 | 1 |
About Hiroaki Saito
Hiroaki Saito is a scholar working on Oncology, Nephrology and Cancer Research, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (24 papers), Bone health and treatments (21 papers), NF-κB Signaling Pathways (7 papers), Parathyroid Disorders and Treatments (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Cancer-related gene regulation (4 papers), TGF-β signaling in diseases (4 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Cancer Research (414 citations), Orthopedics and Sports Medicine (217 citations) and Oncology (659 citations). Hiroaki Saito has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Kazuhiro Aoki, Keiichi Ohya, Roland Baron, Eric Hesse, Sankar Ghosh, Eijiro Jimi, Fulvio D’Acquisto, Ichiro Nakamura, Michael J. May and Koji Okabe. Their work appears in journals such as Journal of Bone and Mineral Research, Tetrahedron, eLife, The Journal of Experimental Medicine and Bone.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.